Expression of the chemokine CCL28 in pleomorphic adenoma and adenolymphoma of the human salivary glands

Experimental and Therapeutic Medicine

Volumn 4, Issue 1, 2012, Pages 65-69

  Liu, Guo Xin ^a   Lan, Jing ^a   Sun, Ying ^b   Hu, Yi Jun ^a   Jiang, Guang Shui ^a  

^a SHANDONG UNIVERSITY   (China)

^b Xiqing Hospital of Tianjin   (China)

Author keywords

Adenolymphoma; CCL28; Chemokine; Pleomorphic adenoma; Salivary gland

Indexed keywords

BETA CHEMOKINE; CCL28 CHEMOKINE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LYMPHOMA; MAJOR CLINICAL STUDY; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR;

EID: 84865721511     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.544     Document Type: Article

References (15)

1. Demasi AP, Furuse C, Soares AB, Altemani A and Araújo VC: Peroxiredoxin I, platelet-derived growth factor A, and plateletderived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Hum Pathol 40: 390-397, 2009.
2. Faur A, Lazar E, Cornianu M, Dema A, Vidita CG and Galuscan A: Warthin tumor: a curious entity - case reports and review of literature. Rom J Morphol Embryol 50: 269-273, 2009.
3. Zlotnik A: Chemokines and cancer. Int J Cancer 119: 2026-2029, 2006.
4. Vandercappellen J, Van Damme J and Struyf S: The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226-244, 2008.
5. Pan J, Kunkel EJ, Gosslar U, Lazarus N, Langdon P, Broadwell K, Vierra MA, Genovese MC, Butcher EC and Soler D: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 165: 2943-2949, 2000.
6. Wang W, Soto H, Oldham ER, Buchanan ME, Homey B, Catron D, Jenkins N, Copeland NG, Gilbert DJ, Nguyen N, et al: Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 275: 22313-22323, 2000.
7. Hieshima K, Ohtani H, Shibano M, Izawa D, Nakayama T, Kawasaki Y, Shiba F, Shiota M, Katou F, Saito T and Yoshie O: CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J Immunol 170: 1452-1461, 2003.
8. Dimberg J, Hugander A and Wagsater D: Protein expression of the chemokine, CCL28, in human colorectal cancer. Int J Oncol 28: 315-319, 2006.
9. Ogawa H, Iimura M, Eckmann L and Kagnoff MF: Regulated production of the chemokine CCL28 in human colon epithelium. Am J Physiol Gastrointest Liver Physiol 287: G1062-G1069, 2004.
10. O'Gorman MT, Jatoi NA, Lane SJ and Mahon BP: IL-1beta and TNF-alpha induce increased expression of CCL28 by airway epithelial cells via an NFkappaB-dependent pathway. Cell Immunol 238: 87-96, 2005.
11. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.
12. Cheroutre H: IELs: enforcing law and order in the court of the intestinal epithelium. Immunol Rev 206: 114-131, 2005.
13. Ebert LA, Schaerli P and Moser B: Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 42: 799-809, 2005.
14. Mickanin CS, Bhatia U and Labow M: Identification of a novel beta-chemokine, MEC, down-regulated in primary breast tumors. Int J Oncol 18: 939-944, 2001.
15. Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L and Coukos G: Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 475: 226-230, 2011.